T. Banisacchi et al., RELAXIN-INDUCED INCREASED CORONARY FLOW-THROUGH STIMULATION OF NITRIC-OXIDE PRODUCTION, British Journal of Pharmacology, 116(1), 1995, pp. 1589-1594
1 Relaxin (RLX) is a multifunctional hormone which, besides its role i
n pregnancy and parturition, has also been shown to influence the card
iovascular system. In this study, we investigated the effect of RLX on
coronary flow of rat and guinea-pig hearts, isolated and perfused in
a Langendorff apparatus. RLX was either added to the perfusion fluid a
t a concentration of 5 x 10(-9) M for a 20-min perfusion, or given as
a bolus into the aortic cannula at concentrations of 10(-9) M, 5 x 10(
-9) M and 10(-8) M dissolved in 1 mi of perfusion fluid.2 RLX, given e
ither for a 20-min perfusion or as a bolus in the aortic cannula to gu
inea-pig and rat isolated hearts, increased the coronary flow and the
amount of nitrite, a stable end-product of nitric oxide (NO) metabolis
m, that appeared in the perfusates in a concentration-dependent fashio
n. 3 The increase in coronary flow and in nitrite in the perfusates in
duced by RLX was significantly reduced by pretreatment with the nitric
oxide synthase (NOS) inhibitor, N-G-monomethyl-L-arginine (L-NMMA, 10
(-4) M). 4 The effects of RLX on coronary flow and nitrite amounts in
the perfusates were compared with those induced by the endothelium-dep
endent vasodilator agent, acetylcholine (ACh, 10(-8) - 10(-7) M), and
by the endothelium-independent vasodilator agent, sodium nitroprusside
(SNP, 10(-7) - 10(-6)M). The results obtained show that RLX is more e
ffective than ACh and SNP in increasing coronary flow. 5 The results o
f this study show that RLX increases coronary flow through stimulation
of NO production; hence this hormone should be regarded as a novel ag
ent capable of improving myocardial perfusion.